Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    3166511 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Drug: indinavir (MK-0639)

Study has passed its completion date and status has not been verified in more than two years.